Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2006 by Groupe Francophone des Myelodysplasies.
Recruitment status was  Recruiting
Information provided by:
Groupe Francophone des Myelodysplasies Identifier:
First received: December 14, 2006
Last updated: March 9, 2007
Last verified: December 2006
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2006
  Estimated Primary Completion Date: No date given